Millennium Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Millennium Management’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2	Closed	-$3K	–	4439
2018 Q4	$3K	Sell	2 -27	-93%	-$64K	﹤0.01%	3690
2018 Q3	$83K	Buy	29 +28	+2,800%	+$80.9K	﹤0.01%	3756
2018 Q2	$4K	Buy	+1	New	+$3.37K	﹤0.01%	3743
2018 Q1	–	Sell	-36	Closed	-$59K	–	4211
2017 Q4	$59K	Buy	+36	New	+$98.1K	﹤0.01%	3711
2015 Q4	–	Sell	-2	Closed	-$36K	–	3873
2015 Q3	$36K	Buy	+2	New	+$55.5K	﹤0.01%	3375

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Millennium Management's TMBR Position: Q1 2019 in Review

Millennium Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2019, closing a stake of 2 shares — an estimated $3K sold.

Millennium Management first reported a position in TMBR in Q3 2015 and held it in 5 quarters. The position peaked at $83K in Q3 2018. 17 funds tracked by Wall St. Rank hold TMBR as of Q1 2019.

Millennium Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Millennium Management sold 2 Timber Pharmaceuticals, Inc. shares in Q1 2019, an estimated $3K.
Millennium Management first reported a position in Timber Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
Millennium Management's Timber Pharmaceuticals, Inc. position peaked at $83K in Q3 2018.
17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2019.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.